본문 바로가기
KERD
논문KCI 등재

급성골수성 백혈병에서 동종조혈모세포 이식 후 고립성 중추신경계 재발에서의 장기 완전 관해 1예

Long-Term Complete Remission in an Acute Myeloid Leukemia Patient with Isolated Central Nervous System Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

이경희|김민경|박정민|정다은|장효진|김명진|배영경|현명수|고성애
영남대학교 의과대학 (Yeungnam University College of Medicine)|2012.12|Journal of Yeungnam Medical Science|제29권 제2호|pp. 96-101

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

LeukemiaCentral nervous systemBone marrow transplantationMeningeal carcinomatosis
주제분류의학일반

초록

Allogeneic hematopoietic stem cell transplantation (HSCT) is considered the optimal curative treatment for acute myeloid leukemia (AML), but some patients develop bone marrow relapse due to remnant leukemia, and few patients develop extramedullary relapse without bone marrow relapse. Isolated extramedullary relapse (IMER) is defined as extramedullary relapse without bone marrow relapse. IMER has been reported in various sites, including the skin, soft tissue, and central nervous system(CNS). Isolated CNS relapse is relatively rare and is associated with poor prognosis due to the absence of an optimal treatment for it. Reported herein is a case involving an adult AML woman who suffered from isolated extramedullary relapse in the CNS after allogeneic HSCT. She was treated with intrathecal chemotherapy and whole-brain and spine radiotherapy, followed by systemic chemotherapy. She is currently well, with no evidence of leukemia recurrence for over six years.

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is considered the optimal curative treatment for acute myeloid leukemia (AML), but some patients develop bone marrow relapse due to remnant leukemia, and few patients develop extramedullary relapse without bone marrow relapse. Isolated extramedullary relapse (IMER) is defined as extramedullary relapse without bone marrow relapse. IMER has been reported in various sites, including the skin, soft tissue, and central nervous system(CNS). Isolated CNS relapse is relatively rare and is associated with poor prognosis due to the absence of an optimal treatment for it. Reported herein is a case involving an adult AML woman who suffered from isolated extramedullary relapse in the CNS after allogeneic HSCT. She was treated with intrathecal chemotherapy and whole-brain and spine radiotherapy, followed by systemic chemotherapy. She is currently well, with no evidence of leukemia recurrence for over six years.

참고문헌 (40)

  1. Zittoun RA, "Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia", N Engl J Med, 332, pp.217~223 (1995)
  2. Burnett A, "Therapeutic advances in acute myeloid leukemia", J Clin Oncol, 29, pp.487~494 (2011)
  3. Santos GW, "Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide", N Engl J Med, 309, pp.1347~1353 (1983)
  4. McGlave PB, "Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission", Blood, 72, pp.1512~1517 (1988)
  5. Clift RA, "Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens", Blood, 76, pp.1867~1871 (1990)
  6. Blaise D, "Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen", Blood, 79, pp.2578~2582 (1992)
  7. Ringdén O, "A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia", Blood, 83, pp.2723~2730 (1994)
  8. Michel G, "Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis", Bone Marrow Transplant, 20, pp.107~112 (1997)
  9. Békássy AN, "Granulocytic sarcoma after allogeneic bone marrow transplantation:a retrospective European multicenter survey", Bone Marrow Transplant, 17, pp.801~808 (1996)
  10. Schäfer H, "Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation", Bone Marrow Transplant, 26, pp.1133~1135 (2000)
  11. Oshima K, "Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation", Biol Blood Marrow Transplant, 14, pp.1100~1107 (2008)
  12. Au WY, "Isolated extramedullary relapse of acute lymphoblastic leukemia after allogeneic bone marrow transplantation", Bone Marrow Transplant, 24, pp.1137~1140 (1999)
  13. Fleming DR, "Lymphocyte infusion for delayed extramedullary relapse of acute leukemia following bone marrow transplantation", Leuk Lymphoma, 21, pp.525~528 (1996)
  14. Forrest DL, "Testicular relapse of acute promyelocytic leukemia after allogeneic BMT", Bone Marrow Transplant, 20, pp.689~690 (1997)
  15. Riseberg DA, "Late extramedullary relapse following bone marrow transplant for AML presenting as acute renal failure and leukemic ascites", Bone Marrow Transplant, 14, pp.1009~1010 (1994)
  16. Thompson CB, "The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia", Blood, 67, pp.195~199 (1986)
  17. Ganem G, "Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission", Cancer, 64, pp.1796~1804 (1989)
  18. Singhal S, "Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission", Bone Marrow Transplant, 17, pp.637~641 (1996)
  19. Craddock CF, "Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML", Bone Marrow Transplant, 41, pp.415~423 (2008)
  20. Lee KH, "Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.", Bone Marrow Transplant, 32, pp.835~842 (2003)
  21. Shimoni A, "Isolated extra-medullary relapse of acute leukemia after allogeneic stem cell transplantation (SCT); different kinetics and better prognosis than systemic relapse", Biol Blood Marrow Transplant, 15(2 suppl), pp.59~ (2009)
  22. Savani BN, "Management of relapse after allo-SCT for AML and the role of second transplantation", Bone Marrow Transplant, 44, pp.769~777 (2009)
  23. Simpson DR, "High incidence of extramedullary relapse of AML after busulfan", cyclophosphamide conditioning and allogeneic stem cell transplantation, 1998, pp.22, 259~264
  24. Tallman MS, "Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia", J Clin Oncol, 11, pp.690~697 (1993)
  25. Chang H, "Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome", Leuk Res, 28, pp.1007~1011 (2004)
  26. Ogawa H, "The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia", Blood, 101, pp.1698~1704 (2003)
  27. Donelli MG, "Do anticancer agents reach the tumor target in the human brain?", Cancer Chemother Pharmacol, 30, pp.251~260 (1992)
  28. Seo S, "Extramedullary relapse in the so-called 'sanctuary'sites for chemotherapy after donor lymphocyte infusion", Bone Marrow Transplant, 25, pp.226~227 (2000)
  29. Chong G, "Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy", Bone Marrow Transplant, 26, pp.1011~1015 (2000)
  30. Sackstein R., "A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease", Biol Blood Marrow Transplant, 12(1 Suppl 1), pp.2~8 (2006)
  31. Ostronoff M, "Reduced intensity conditioning allogeneic bone marrow transplantation following central nervous system(CNS) relapse of acute promyelocytic leukemia:evidence for a graft-versus-leukemia effect in the CNS", Am J Hematol, 81, pp.387~388 (2006)
  32. Porter DL, "Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions", Blood, 95, pp.1214~1221 (2000)
  33. Kolb HJ, "Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients", Blood, 86, pp.2041~2050 (1995)
  34. Au WY, "Acute myeloid leukemia relapsing as gynecomastia", Leuk Lymphoma, 36, pp.191~194 (1999)
  35. Thompson CB, "The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia", Blood, 67, pp.195~199 (1986)
  36. Ando T, "Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation", Tohoku J Exp Med, 220, pp.121~126 (2010)
  37. Wadleigh M, "Prior emtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation", Blood, 102, pp.1578~1582 (2003)
  38. Graef T, "Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine", Leuk Res, 31, pp.257~259 (2007)
  39. Jabbour E, "Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia", Cancer, 115, pp.1899~1905 (2009)
  40. Oka Y, "Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product", Immunogenetics, 51, pp.99~107 (2000)

관련 논문AI추천

AML1/ETO 양성 급성 골수성 백혈병 환자에서 동종 조혈모세포 이식 이후에 골수 외 재발된 2예김미경, 김춘추, 김희제, 민우성, 송명준, 엄기성, 이진국대한내과학회 · 대한내과학회지2006 · 제70권 제2호A Case of Isolated Lymphoblastic Relapse of the Central Nervous System in a Patient with Chronic Myelogenous Leukemia Treated with Imatinib김경희, 김문진, 박미정, 박진희, 박필환, 서일혜, 서자영, 안정열, 정지훈, 정진우대한진단검사의학회 · Annals of Laboratory Medicine2014 · 제34권 제3호동종 조혈모세포이식 후 골수는 정상이나 난소종양으로 재발한 급성 T 세포 림프구성 백혈병 1예강은숙, 문희원, 성주명, 이미애, 정화순, 허정원, 허희진대한진단검사의학회 · Annals of Laboratory Medicine2003 · 제23권 제2호급성골수구성백혈병에서 재발의 첫 임상증상으로 나타난 시신경유두 침범의 1예박새미, 박성규, 박태관대한안과학회 · 대한안과학회지2011 · 제52권 제2호Isolated central nervous system relapse in blast crisis of chronic myeloid leukemia: a case reportJamian Ehram, Liang Boo Yang, Ling Caroline Ho Siew, Raghvan Hari Priya, Subbiah Indhira, Yui Wee Shiang영남대학교 의과대학 · Journal of Yeungnam Medical Science2025 · 제42권 관해 유도 후 글리벡과 동종 조혈모세포 이식으로 치료한 필라델피아 염색체 양성 급성 골수성백혈병 3예김춘추, 김희제, 남해성, 민우성, 박윤정, 엄기성, 윤재호대한내과학회 · 대한내과학회지2007 · 제72권 제3호

이 간행물의 다른 논문 (17건)

소아에서의 비만과 인슐린 저항성최광해pp. 73-76AMP-activated protein kinase 활성화 기전과 관련 약물의 효과최형철pp. 77-82항산균 배양에서 BACTEC MGIT 960 System의 유용성 및 MGIT 양성배지에서 결핵균 진단을 위한 TB Ag MPT64 면역발색법의 유용성김유은, 이승준, 이정미, 김선주, 임수진, 이민정, 이종덕, 김호철, 정이영, 황영실, 조유지, 이승훈pp. 83-88소아에서 마이코플라즈마 폐렴의 예기적 진단김원덕, 박수진, 이창언pp. 89-95만성신질환의 경과 중 급성 악화를 보인 허탈성 사구체병증의 진단 1예이한솔, 황문주, 박정민, 정요한, 김용진, 박종원pp. 102-105
원문 보기